Vistin Pharma ASA (VISTN) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.16x

Vistin Pharma ASA (VISTN) has a Cash Flow Reinvestment Rate of 0.16x as of December 2025, reinvesting Nkr6.51 Million (capex Nkr6.51 Million ) from operating cash flow of Nkr40.81 Million. See VISTN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.16x
(Capex + Investments) / Operating CF

Total Reinvested

Nkr6.51 Million
Capex + Investments

Operating Cash Flow

Nkr40.81 Million
NOK

Capital Expenditures

Nkr6.51 Million
NOK

Vistin Pharma ASA Cash Flow Reinvestment Rate (2016–2025)

Historical reinvestment intensity for Vistin Pharma ASA across 7 annual periods. For the full cash flow conversion analysis, see Vistin Pharma ASA (VISTN) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for Vistin Pharma ASA (2016–2025)

Year-by-year capital reinvestment analysis for Vistin Pharma ASA. See Vistin Pharma ASA (VISTN) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (NOK) Operating CF Capex YoY Change
2025 0.21x Nkr16.68 Million Nkr78.04 Million Nkr16.68 Million ▼ -71.6%
2024 0.75x Nkr81.10 Million Nkr107.86 Million Nkr40.80 Million ▲ +91.4%
2023 0.39x Nkr35.58 Million Nkr90.59 Million Nkr17.90 Million ▼ -91.6%
2021 4.65x Nkr63.62 Million Nkr13.68 Million Nkr31.94 Million ▲ +139.8%
2019 1.94x Nkr36.71 Million Nkr18.93 Million Nkr18.36 Million ▼ -88.4%
2017 16.67x Nkr158.48 Million Nkr9.51 Million Nkr35.55 Million ▲ +2672.1%
2016 0.60x Nkr32.37 Million Nkr53.84 Million Nkr16.27 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow